Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1918 1
1937 1
1945 9
1946 35
1947 46
1948 38
1949 32
1950 45
1951 67
1952 54
1953 79
1954 125
1955 121
1956 176
1957 187
1958 200
1959 222
1960 358
1961 404
1962 610
1963 1011
1964 1610
1965 1314
1966 1323
1967 1649
1968 2118
1969 2855
1970 3078
1971 3476
1972 3578
1973 3886
1974 3882
1975 4110
1976 3919
1977 3873
1978 3988
1979 4317
1980 4058
1981 4330
1982 4693
1983 5039
1984 5749
1985 6078
1986 6206
1987 7100
1988 7291
1989 8058
1990 7935
1991 8366
1992 8905
1993 9020
1994 9679
1995 9758
1996 10521
1997 10203
1998 10739
1999 10787
2000 11643
2001 12279
2002 12542
2003 13394
2004 14075
2005 15603
2006 16355
2007 16830
2008 17712
2009 18589
2010 19437
2011 20730
2012 21555
2013 21892
2014 22287
2015 22421
2016 21920
2017 21717
2018 21802
2019 21003
2020 13100
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

545,815 results
Results by year
Filters applied: . Clear all
Page 1
Tolerance after liver transplantation: Where are we?
Feng S, Bucuvalas J. Feng S, et al. Liver Transpl. 2017 Dec;23(12):1601-1614. doi: 10.1002/lt.24845. Liver Transpl. 2017. PMID: 28834221 Free article. Review.
Too little risks chronic, often subclinical allo-immune injury while too much risks insidious and cumulative toxicities. Historically, immunosuppression minimization or withdrawal has been a strategy to optimize the longevity of liver transplant recipients. ...More …
Too little risks chronic, often subclinical allo-immune injury while too much risks insidious and cumulative toxicities. Historically …
Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.
Shaked A, DesMarais MR, Kopetskie H, Feng S, Punch JD, Levitsky J, Reyes J, Klintmalm GB, Demetris AJ, Burrell BE, Priore A, Bridges ND, Sayre PH. Shaked A, et al. Am J Transplant. 2019 May;19(5):1397-1409. doi: 10.1111/ajt.15205. Epub 2018 Dec 31. Am J Transplant. 2019. PMID: 30506630 Free PMC article. Clinical Trial.
The Immune Tolerance Network ITN030ST A-WISH assessed immunosuppression withdrawal in liver transplant recipients with hepatitis C or nonimmune nonviral liver disease. ...Immunosuppression withdrawal followed an 8-step reduction algorithm with ≥8 weeks …
The Immune Tolerance Network ITN030ST A-WISH assessed immunosuppression withdrawal in liver transplant recipients with …
Immunosuppression and probiotics: are they effective and safe?
Stadlbauer V. Stadlbauer V. Benef Microbes. 2015;6(6):823-8. doi: 10.3920/BM2015.0065. Epub 2015 Aug 19. Benef Microbes. 2015. PMID: 26287986 Review.
This opinion statement discusses indications, efficacy and safety of probiotics in immunosuppressed patients. The best evidence available is for the prophylaxis of infections in patients after liver transplantation and for patients with liver cirrhosis. ...
This opinion statement discusses indications, efficacy and safety of probiotics in immunosuppressed patients. The best evidence avail …
Immunosuppression in Solid-Organ Transplantation: Essentials and Practical Tips.
Jasiak NM, Park JM. Jasiak NM, et al. Crit Care Nurs Q. 2016 Jul-Sep;39(3):227-40. doi: 10.1097/CNQ.0000000000000117. Crit Care Nurs Q. 2016. PMID: 27254639 Review.
This review discusses mechanism of action, indication, side effects, and drug interactions of commonly used immunosuppressive medications in solid-organ transplantation. ...
This review discusses mechanism of action, indication, side effects, and drug interactions of commonly used immunosuppressive medicat …
Immunosuppression in pediatric liver transplant recipients: Unique aspects.
Miloh T, Barton A, Wheeler J, Pham Y, Hewitt W, Keegan T, Sanchez C, Bulut P, Goss J. Miloh T, et al. Liver Transpl. 2017 Feb;23(2):244-256. doi: 10.1002/lt.24677. Epub 2017 Jan 17. Liver Transpl. 2017. PMID: 27874250 Free article. Review.
Physiologic differences in children alter the pharmacokinetics of immunosuppressive agents, which affects absorption, distribution, metabolism, and drug excretion. ...Further advances in the field of tolerance and accommodation are needed to relieve the acute …
Physiologic differences in children alter the pharmacokinetics of immunosuppressive agents, which affects absorption, distribu …
Immunosuppression.
Derek E, Dhanireddy K. Derek E, et al. Curr Opin Organ Transplant. 2012 Dec;17(6):616-8. doi: 10.1097/MOT.0b013e32835a7d3a. Curr Opin Organ Transplant. 2012. PMID: 23095440 No abstract available.
Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression.
Johnson KM, Belfer JJ, Peterson GR, Boelkins MR, Dumkow LE. Johnson KM, et al. Pharmacotherapy. 2020 Jun;40(6):517-524. doi: 10.1002/phar.2410. Epub 2020 May 26. Pharmacotherapy. 2020. PMID: 32339304 Free PMC article. Review.
The Centers for Disease Control and Prevention (CDC) lists immunocompromised patients, including those requiring immunosuppression following renal transplantation, as high risk for severe disease from SARS-CoV-2. ...Recently published cases describing inpatient care …
The Centers for Disease Control and Prevention (CDC) lists immunocompromised patients, including those requiring immunosuppression
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature.
Manzia TM, Angelico R, Gazia C, Lenci I, Milana M, Ademoyero OT, Pedini D, Toti L, Spada M, Tisone G, Baiocchi L. Manzia TM, et al. World J Gastroenterol. 2019 Sep 21;25(35):5356-5375. doi: 10.3748/wjg.v25.i35.5356. World J Gastroenterol. 2019. PMID: 31558879 Free PMC article.
BACKGROUND: Immunosuppression has undoubtedly raised the overall positive outcomes in the post-operative management of solid organ transplantation. ...AIM: To study the role of immunosuppression on the incidence of de novo malignancies in liver transplant recipients …
BACKGROUND: Immunosuppression has undoubtedly raised the overall positive outcomes in the post-operative management of solid organ tr …
Tolerance in clinical liver transplantation.
Levitsky J, Feng S. Levitsky J, et al. Hum Immunol. 2018 May;79(5):283-287. doi: 10.1016/j.humimm.2017.10.007. Epub 2017 Oct 18. Hum Immunol. 2018. PMID: 29054397 Review.
While advances in immunosuppressive therapy have lowered the rate of acute rejection following liver transplantation, the consequence has been an increase in morbidity and mortality related to the lifelong need for maintenance immunosuppression. ...This review will …
While advances in immunosuppressive therapy have lowered the rate of acute rejection following liver transplantation, the consequence …
Biomarkers of immune tolerance in liver transplantation.
Vionnet J, Sánchez-Fueyo A. Vionnet J, et al. Hum Immunol. 2018 May;79(5):388-394. doi: 10.1016/j.humimm.2018.02.010. Epub 2018 Feb 17. Hum Immunol. 2018. PMID: 29462637 Review.
The liver exhibits intrinsic immune tolerogenic properties that contribute to a unique propensity toward spontaneous acceptance when transplanted, both in animal models and in humans. ...Significant efforts have been put into identifying sensitive and specific biomarkers o …
The liver exhibits intrinsic immune tolerogenic properties that contribute to a unique propensity toward spontaneous acceptance when …
545,815 results
Jump to page
Feedback